Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa Mariani

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Cancer Research|August 14, 2015
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancerMarta De Donato, Mara Fanelli, Marisa Mariani, et al.
Oncotarget|July 3, 2015
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancerSilvia Prislei, Enrica Martinelli, Gian Franco Zannoni, et al.
Cancer Research|December 17, 2008
Molecular mechanisms of patupilone resistanceSimona Mozzetti, Raffaella Iantomasi, Ilaria De Maria, et al.
Plos One|December 9, 2014
Herpes virus microRNA expression and significance in serous ovarian cancerDeep Pandya, Marisa Mariani, Mark McHugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2012
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancerMarisa Mariani, Gian Franco Zannoni, Stefano Sioletic, et al.
Journal of Cellular Physiology|April 27, 2011
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancerMarta De Donato, Marisa Mariani, Lella Petrella, et al.
Oncotarget|June 23, 2014
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancerMarisa Mariani, Mark McHugh, Marco Petrillo, et al.
European Journal of Medicinal Chemistry|August 2, 2014
GTP is an allosteric modulator of the interaction between the guanylate-binding protein 1 and the prosurvival kinase PIM1Marco Persico, Lella Petrella, Nausicaa Orteca, et al.
Gene|March 26, 2014
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressivenessGiuseppina Raspaglio, Marco Petrillo, Enrica Martinelli, et al.
Journal of Medicinal Chemistry|September 12, 2014
Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cellsMirko Andreoli, Marco Persico, Ajay Kumar, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Cancer Research|August 14, 2015
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancerMarta De Donato, Mara Fanelli, Marisa Mariani, et al.
Oncotarget|July 3, 2015
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancerSilvia Prislei, Enrica Martinelli, Gian Franco Zannoni, et al.
Cancer Research|December 17, 2008
Molecular mechanisms of patupilone resistanceSimona Mozzetti, Raffaella Iantomasi, Ilaria De Maria, et al.
Plos One|December 9, 2014
Herpes virus microRNA expression and significance in serous ovarian cancerDeep Pandya, Marisa Mariani, Mark McHugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2012
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancerMarisa Mariani, Gian Franco Zannoni, Stefano Sioletic, et al.
Journal of Cellular Physiology|April 27, 2011
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancerMarta De Donato, Marisa Mariani, Lella Petrella, et al.
Oncotarget|June 23, 2014
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancerMarisa Mariani, Mark McHugh, Marco Petrillo, et al.
European Journal of Medicinal Chemistry|August 2, 2014
GTP is an allosteric modulator of the interaction between the guanylate-binding protein 1 and the prosurvival kinase PIM1Marco Persico, Lella Petrella, Nausicaa Orteca, et al.
Gene|March 26, 2014
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressivenessGiuseppina Raspaglio, Marco Petrillo, Enrica Martinelli, et al.
Journal of Medicinal Chemistry|September 12, 2014
Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cellsMirko Andreoli, Marco Persico, Ajay Kumar, et al.
Pageof 3